CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash (used in) provided by operating activities
Net loss	$ (2,599)	$ (18,150)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Amortization of intangible assets	541	634
Depreciation	1,206	1,266
Stock-based compensation expense	203	109
Amortization of financing fees	837	1,158
Deferred income taxes	372	369
Other adjustments, net	343	574
Changes in operating assets and liabilities:
Accounts receivable, net	(6,140)	7,620
Inventory, net	3,182	(1,363)
Prepaid expenses and other assets	(739)	(84)
Accounts payable	(10,777)	24,287
Other current liabilities	1,706	(11,144)
Other noncurrent liabilities	(5,512)	405
Net cash (used in) provided by operating activities	(17,377)	5,681
Cash used in investing activities
Capital expenditures	(116)	(617)
Other investing activities, net	0	10
Net cash used in investing activities	(116)	(607)
Cash provided by (used in) financing activities
Repayments of long-term debt and lease liabilities	(87)	(102)
Proceeds from short-term financings	15,000	0
Payments of deferred financing costs	(1,725)	(2,536)
Net cash provided by (used in) financing activities	13,188	(2,638)
Net (decrease) increase in cash, cash equivalents, and restricted cash	(4,305)	2,436
Cash, cash equivalents, and restricted cash at beginning of the period	9,732	24,267
Cash, cash equivalents, and restricted cash at end of the period	5,427	26,703
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets
Cash and cash equivalents	2,267	23,404
Restricted cash	3,160	3,299
Total cash, cash equivalents, and restricted cash	$ 5,427	$ 26,703